Concepedia

Hilary Glen

HG

Statistics

Publications

23

Citations

1.8K

H-Index

16

Active since

2005

Affiliations

Beatson West of Scotland Cancer Centre(Current)

The Christie NHS Foundation Trust

Royal Marsden NHS Foundation Trust

St James's University Hospital

Nottingham University Hospitals NHS Trust

Hilary Glen is an author at Beatson West of Scotland Cancer Centre specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2005–2024

23

Publications

23

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Robert J. Motzer, Thomas E. Hutson, Hilary Glen et al. · The Lancet Oncology · 2015 · 929 citations

, , +4

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

David S. Boss, Hilary Glen, Jos H. Beijnen et al. · British Journal of Cancer · 2012 · 185 citations · Full text

, , +6

E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion

Hilary Glen, Susan Mason, Hitesh Patel et al. · BMC Cancer · 2011 · 87 citations · Full text

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard, Laura Murphy, Noel W. Clarke et al. · The Lancet Oncology · 2023 · 85 citations · Full text

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)

Cristina Suárez, James Larkin, Poulam Patel et al. · Journal of Clinical Oncology · 2023 · 73 citations

Rows per page

1–5 of 23